ARLENE ROBERTS: Open Payments
NPI 1811777550 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $132 |
| AstraZeneca Pharmaceuticals LP | 2 | $54 |
| GENZYME CORPORATION | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $35 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Viatris Specialty LLC | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Electromed, Inc. | 4 | $21 |
Products named: DUPIXENT, FASENRA, WINREVAIR, OPSYNVI, YUPELRI, Ohtuvayre, SMARTVEST.
Industry payments across NV — which companies pay providers there.
